Inhaled Short Acting Beta2 Agonists Sabas

Drug Overview

Time taken to compute- 0.015 sec

drug details
nameInhaled Short-Acting Beta2 Agonists (e.g., SABAs)
classificationBronchodilators, sympathomimetics
pharmacokinetics
absorptionRapidly absorbed via inhalation, achieving peak effect within minutes.
distributionDistributed throughout the respiratory system, primarily affecting the bronchi and bronchioles.
metabolismMetabolized primarily in the liver.
excretionExcreted primarily through the kidneys.
suggested dosage
noteDosage varies significantly depending on the specific medication and individual patient response. It's crucial to follow the prescribed dosage and instructions from a healthcare professional.
exampleCommonly inhaled as needed; doses should be tailored based on individual needs and symptom severity. Consult physician for specific dosage guidelines.
considerations
1Patient weight and age, and severity of asthma or COPD
2Frequency of use and potential for tachyphylaxis (tolerance)
indications
1Treatment of acute bronchospasm, such as during an asthma attack or COPD exacerbation.
2Prevention of exercise-induced bronchospasm.
safety in pregnancy
noteSABAs are generally considered safe for use during pregnancy, although potentially teratogenic effects are not completely ruled out, particularly in the first trimester.
recommendationUse only as prescribed by an obstetrician/gynecologist during pregnancy.
safety in breastfeeding
noteSABAs are generally considered safe for use during breastfeeding, with minimal amounts likely to be transferred into breast milk.
recommendationUse only as prescribed by a pediatrician, if breastfeeding.
side effects
1Tremor
2Tachycardia
3Palpitations
4Headache
5Anxiety
6Nausea
7Muscle cramps
8Dry mouth
9Possible worsening of asthma in some cases.
alternatives
1Long-acting beta2 agonists (LABAs)
2Theophylline
3Anticholinergics (e.g., ipratropium bromide)
4Leukotriene modifiers
contraindications
1Known hypersensitivity to beta2 agonists or other components of the medication
2Severe heart disease
3Uncontrolled hyperthyroidism
interactions
1Caution with concurrent use of other medications that affect heart rate or blood pressure.
2May enhance the effects of other bronchodilators but also increase risk of side effects
warnings and precautions
1Monitor for excessive use which may indicate uncontrolled asthma/COPD and requires further evaluation.
2Patient education on proper inhaler technique is crucial.
3Do not use excessively or for prolonged periods without medical supervision. Repeated use might lead to tolerance (tachyphylaxis) and reduced effectiveness.
4May mask or delay the onset of life-threatening respiratory symptoms, thus needing further evaluation.
additional information
noteThis information is for general knowledge only and does not constitute medical advice. Consult a healthcare professional for personalized guidance regarding your specific condition and treatment options.
important notesSABAs are rescue medications. They provide rapid relief but do not treat the underlying causes of asthma or COPD. If you experience persistent or worsening symptoms, consult a physician immediately.
patient specific info
age and weight considerationsWhile age and weight are not primary factors influencing dosage for SABAs, they are taken into consideration in determining dosage and frequency. The 25-year-old, 70kg patient should follow prescribed dosage and frequency of use.

Check another drug or interactions

Most Frequent Searches

Reference Patient:(25 years,Male, 70KGs) *Not a medical advice

Get in Touch Now!

Contact Us